Core Viewpoint - FibroBiologics, Inc. has successfully closed the third $5 million tranche of a Standby Equity Purchase Agreement (SEPA) with Yorkville Advisors, allowing the company to raise up to $25 million over two years for its therapeutic development efforts [1][2]. Financing Details - The SEPA allows FibroBiologics to sell up to $25 million in common stock to Yorkville over two years, with the first three tranches totaling $15 million being advanced in equal parts of $5 million each [2]. - The third tranche of $5 million was funded after the effectiveness of a registration statement and shareholder approval, complying with Nasdaq rules [2]. Use of Proceeds - The net proceeds from this financing are intended for general corporate purposes, including funding research and development programs and supporting an upcoming Phase 1/2 clinical trial for diabetic foot ulcers expected to start in the second half of 2025 [3]. Company Overview - FibroBiologics is a clinical-stage biotechnology company based in Houston, focusing on developing therapeutics and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials [7][8]. - The company holds over 275 patents issued and pending, covering various clinical pathways such as wound healing, multiple sclerosis, and cancer [8].

Core Insights - Coherent Corp. has expanded its PowerMax™ sensor portfolio with the introduction of the PM15K+ high-power laser sensor and a backscatter shield for the PM10K+, addressing the increasing demand for precise and safe high-power laser measurements in industrial settings [1][4] Group 1: Product Innovations - The PM15K+ sensor can measure continuous laser power up to 15 kW and intermittent power up to 20 kW, featuring a large active area of 100 mm x 100 mm, suitable for high-power diode and fiber laser systems [2] - The PM15K+ sensor has a response time of 5 seconds, making it ideal for high-throughput industrial applications requiring quick and reliable measurements [2] - The new backscatter shield for the PM10K+ sensor significantly enhances measurement accuracy by reducing reflected laser energy from 10-15% to 1% or less, thus improving safety for surrounding equipment and personnel [3] Group 2: Market Applications - Both the PM15K+ and the enhanced PM10K+ are compatible with Coherent's LabMax-Pro and PowerMax-Pro systems, supporting a variety of applications in industrial manufacturing, scientific research, and medical laser fields [4]

Core Insights - Shoals Technologies Group, Inc. has appointed Bobbie L. King, Jr. as Chief Legal Officer and Corporate Secretary to enhance its legal strategy and support sustainable growth [1][2][3] Company Overview - Shoals Technologies Group is a leading provider of electrical balance of system solutions and components for the global energy transition market, including battery energy storage solutions [4] - The company has been recognized for its innovative technologies that improve installation efficiency, safety, and system performance since its founding in 1996 [4] Executive Team Enhancement - Bobbie L. King, Jr. brings over 15 years of legal and leadership experience in the clean infrastructure industry, previously serving at HA Sustainable Infrastructure Capital, Inc. and holding senior roles at NextEra Energy, Inc. and Charles River Laboratories [2][3] - The CEO of Shoals, Brandon Moss, expressed confidence in Mr. King's ability to drive operational efficiencies and support growth within the company [3]

Company Overview - Aemetis, Inc. reported total revenues of $42.9 million in Q1 2025, a decline from $72.6 million in the same period last year, primarily due to shifts in timing for new government biodiesel contracts in India [1] - The net loss for the quarter was $24.5 million, relatively flat compared to a net loss of $24.2 million in Q1 2024, reflecting ongoing investments in growth initiatives and higher interest expenses [1] - The company ended the quarter with $0.5 million in cash, down from $0.9 million at year-end, although liquidity was supported by $19.0 million in cash proceeds from the sale of transferable investment tax credits [1] Industry Developments - Federal and state-level policy developments include a nationwide move from E10 to year-round E15 ethanol blends, expanding low-carbon fuel standards, and the IRS establishing provisional emissions rates for dairy RNG and 45Z production tax credits [6] - Aemetis RNG is gaining traction with operational production facilities, reporting a 140% year-over-year revenue increase in Q1 2025, with 19 dairy digesters operational and 26 expected to be online by year-end [6] - The ethanol and India biofuels segments continue to perform well due to long-term infrastructure upgrades and favorable policy support, despite short-term pricing pressures; ethanol operations benefit from completed solar microgrid upgrades and the development of the MVR system, while India biofuels grew by 27% in Q1 and is preparing for a potential IPO [6]

Core Viewpoint - Reliance Global Group, Inc. has filed a request for withdrawal of its Registration Statement on Form S-1 with the SEC, indicating it will not pursue a public offering at this time [1] Company Overview - Reliance Global Group, Inc. is an InsurTech pioneer utilizing artificial intelligence and cloud-based technologies to enhance efficiencies in the insurance agency and brokerage industry [3] - The company's B2B platform, RELI Exchange, offers independent insurance agencies a suite of business development tools to compete with larger national agencies while reducing operational costs [3] - The B2C platform, 5minuteinsure.com, provides quick online insurance quotes for auto, home, and life insurance using AI and data mining [3] - The company also operates a portfolio of retail insurance agencies across the United States, offering a variety of insurance products [3]

Core Insights - Castle Biosciences has entered a collaboration and license agreement with SciBase to develop a diagnostic test aimed at predicting flares in patients with atopic dermatitis [1][2][3] - The collaboration targets a potential market of up to 24 million patients in the United States suffering from atopic dermatitis, many of whom experience flares while on maintenance treatment [2][3] - SciBase's technology will be utilized to enhance patient care in dermatology, complementing Castle's existing portfolio of tests for skin cancers and other dermatological conditions [3][5] Company Overview - Castle Biosciences is a diagnostics company focused on innovative tests that guide patient care, with a mission to transform disease management [4] - The company's current portfolio includes tests for skin cancers, Barrett's esophagus, and uveal melanoma, along with ongoing research for additional tests in high clinical need areas [5] Collaboration Details - Under the agreement, both companies will explore various clinical indications related to dermatologic diseases, with SciBase focusing on the EU, Switzerland, UAE, Japan, and South Korea, while Castle will target North America [3] - SciBase will receive a single-digit royalty on Castle's gross margin and a low double-digit percentage markup on product sales, along with a milestone payment of 5 million USD when Castle's sales reach 50 million USD annually [3]

Group 1 - Steppe Gold Ltd. held its annual general and special meeting of shareholders on June 16, 2025, where key voting results were announced [1][2] - Seven individuals were elected to serve on the Board of Directors, with Batjargal Zamba and Jargalan Sereenen receiving the highest approval rates of 99.78% and 99.80% respectively [2] - Byambatseren Tsogbadrakh received more votes withheld (155,974,798) than votes in favor (15,704,475), necessitating her resignation submission to the Board as per the company's majority voting policy [2][6] Group 2 - Kingston Ross Pasnak LLP was re-appointed as auditors for Steppe Gold until the next annual meeting, with the Board authorized to fix their remuneration [2] - The shareholders did not pass the ordinary resolution for the ratification and adoption of the Company's long-term incentive plan, with only 9.15% voting in favor [5][6] Group 3 - Steppe Gold Ltd. is recognized as Mongolia's premier precious metals company [7]

Core Insights - Dime Community Bancshares, Inc. has announced the hiring of Shawn Gines as Executive Vice President, Corporate and Specialty Finance, as part of its growth strategy [1][2] - Gines will focus on expanding Dime's commercial lending business, particularly with corporate clients and private equity firms, and will oversee the newly launched Fund Finance vertical [2][3] - The company aims to diversify its balance sheet through the development of various specialty verticals [2] Company Overview - Dime Community Bancshares, Inc. is the parent company of Dime Community Bank, which has over $14 billion in assets and holds the number one deposit market share among community banks in Greater Long Island [5][6] - The bank is recognized for its strong market presence and is considered a preferred employer for talented bankers [3][4] Leadership and Experience - Shawn Gines brings extensive experience to Dime, having previously served as Regional President for the NYC and New Jersey Metro Markets at Webster Bank and as Senior Managing Director at Sterling National Bank [4] - His background includes roles at GE Capital and Bank of America, contributing to his strong track record in the banking industry [4] Strategic Goals - The hiring of Gines is seen as a cornerstone for Dime's growth plans, with expectations that his diverse experience will accelerate the bank's execution of its strategic initiatives [3] - The focus on corporate clients and private equity firms indicates a strategic shift towards enhancing Dime's commercial lending capabilities [2][3]

Great Place to Work Certification™ reflects MSC's commitment to being an employer-of-choice.MELVILLE, N.Y. and DAVIDSON, N.C., June 16, 2025 /PRNewswire/ -- MSC INDUSTRIAL SUPPLY CO. (NYSE: MSM), a premier distributor of Metalworking and Maintenance, Repair and Operations supplies to industrial customers throughout North America, is proud to announce it has been Certified™ by Great Place To Work® for the second consecutive year in the United States, as well as in Canada, Mexico, and the United Kingdom for t ...

Mobile-health Network Solutions Announces H1 FY2025 Results; Continues on Drive Towards Scale and ProfitabilityJune 16, 2025 4:30 PM EDT | Source: Mobile-health Network SolutionsSingapore, Singapore--(Newsfile Corp. - June 16, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today announced financial results for the first six months of its fiscal year 2025 ("H1 FY2025").H1 FY2025 per ...